drugset / Trial / NCT01254552
Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
NaSingle-groupOpen-labelDiagnostic
Summary
The study aimed to prospectively investigate the prevalence of myocardial scar on Dotarem-enhanced Cardiovascular Magnetic Resonance Imaging (MRI) in asymptomatic patients with type-2 Diabetes Mellitus and to assess its correlation with subclinical coronary artery disease on Cardiac Computed Tomography Angiography (CCTA).
Timeline
- Start
- 2010-08
- Primary completion
- 2011-09
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadoterate meglumine | Diagnostic / imaging agent | 0.1 unknown | — |
| Subject | Iobitridol | Diagnostic / imaging agent | 180 ml | — |